Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
In time for this year’s Great American Smokeout, St. Jude Children’s Research Hospital expands its smoking cessation efforts by offering free counseling and nicotine replacement therapy to survivors of childhood or adult-onset cancer
Cancer survivors who smoke and need help quitting can receive help through a tobacco cessation program organized by St. Jude Children’s Research Hospital.
Despite the known risk of tobacco use, many cancer survivors still smoke. Cancer and its treatments put some survivors at increased risk for second cancers and conditions such as diabetes, heart disease and stroke. Smoking adds to health risks.
The Cancer Survivor Tobacco Quit Line is open to survivors of childhood or adult-onset cancer, regardless of where they received treatment. Participation in the program is free.
“St. Jude has several efforts in place to help with the transition from patient to survivor,” said Robert Klesges, Ph.D., of the St. Jude Epidemiology and Cancer Control department. “The quit line is another way for us to help survivors be conscious about their health, understand the health risks associated with their treatment and help improve their quality of life.”
In recent years, smoking prevention and cessation efforts in the United States have included public smoking bans, the establishment of toll-free quit lines and the Great American Smokeout event nationwide, which is organized annually to encourage smokers to quit. This year’s event is November 18.
To address the unique needs of cancer survivors who smoke, St. Jude created the Cancer Survivor Tobacco Quit Line through a grant from the National Cancer Institute. The quit line first started as a smoking cessation program aimed at childhood cancer survivors, but this year the program expanded to include survivors of adult-onset cancer as well.
Through the quit line, participants are assigned to one of two interventions: a counselor-initiated group or a self-paced group. All of the St. Jude counselors hold advanced degrees and have professional experience in public health to assist participants in preparing to quit, setting quit dates and avoiding relapses.
In the counselor-initiated group, St. Jude counselors call participants six times during an eight-week period. Smokers in the self-paced group receive the same intervention but are responsible for phoning the counselors. All participants receive nicotine-replacement therapy in the form of patches or gum.
Participation in the quit line study is confidential, and survivors may end participation at any time. To qualify, survivors must be 18 years or older; speak English; have telephone access and live in the U.S.
To enroll, cancer survivors can call (877) 4SJ-QUIT (475-7848), or visit www.stjude.org/breakfreefromsmoking for more information about the tobacco cessation study.
St. Jude Children's Research Hospital
St. Jude Children’s Research Hospital is internationally recognized for its pioneering research and treatment of children with cancer and other catastrophic diseases. Ranked the No. 1 pediatric cancer hospital by Parents magazine and the No. 1 children’s cancer hospital by U.S. News & World Report, St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. St. Jude has treated children from all 50 states and from around the world, serving as a trusted resource for physicians and researchers. St. Jude has developed research protocols that helped push overall survival rates for childhood cancer from less than 20 percent when the hospital opened to almost 80 percent today. St. Jude is the national coordinating center for the Pediatric Brain Tumor Consortium and the Childhood Cancer Survivor Study. In addition to pediatric cancer research, St. Jude is also a leader in sickle cell disease research and is a globally prominent research center for influenza.
Founded in 1962 by the late entertainer Danny Thomas, St. Jude freely shares its discoveries with scientific and medical communities around the world, publishing more research articles than any other pediatric cancer research center in the United States. St. Jude treats more than 5,700 patients each year and is the only pediatric cancer research center where families never pay for treatment not covered by insurance. St. Jude is financially supported by thousands of individual donors, organizations and corporations without which the hospital’s work would not be possible. In 2010, St. Jude was ranked the most trusted charity in the nation in a public survey conducted by Harris Interactive, a highly respected international polling and research firm.